Physician profile
William M Noorlag
NPI 1538163456
$3,489.79
in general payments reported to CMS, 2019-2025
11 companies · $155 in 2025
The $155 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $389 · 2020: $31.35 · 2021: $77.05 · 2022: $413 · 2023: $2,425 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,020 · Food and Beverage: $560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,020.21 |
| Food and Beverage | $559.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $2,771.04 | 2019-2025 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Stryker Corporation | $208.14 | 2019-2022 | |
| Paragon 28, INC. | $109.14 | 2019 | |
| Osiris Therapeutics INC. | $104.45 | 2019 | |
| Zimmer Biomet Holdings, INC. | $103.00 | 2019 | |
| Orthofix Medical, INC. | $80.34 | 2022 | |
| Bioventus LLC | $34.02 | 2021-2025 | Exogen Ultrasound Bone Healing System |
| Acera Surgical, INC. | $27.43 | 2021 | |
| Treace Medical Concepts, INC. | $23.59 | 2025 | |
| Medartis INC. | $15.60 | 2021 | |
| Next Science LLC | $13.04 | 2023 | Surgx, Blastx, Xperience |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Noorlag listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.